16 results
8-K
EX-99.1
NEXI
Neximmune Inc
12 May 22
NexImmune Reports First Quarter 2022 Financial Results and Provides Business Updates
4:16pm
the appointment of Dr. Leena Gandhi, Director of Dana-Farber’s Center for Cancer Therapeutic Innovation, to NexImmune’s Board of Directors
Continued
8-K
EX-99.1
aqn562
10 May 22
NexImmune Announces Appointment of Dr. Leena Gandhi to its Board of Directors
7:43am
8-K
hbxansv48l2yq
10 May 22
NexImmune Announces Appointment of Dr. Leena Gandhi to its Board of Directors
7:43am
DEF 14A
wmn1fs7cj5
3 May 22
Definitive proxy
4:16pm
10-K
o9tu1 nwyj
31 Mar 21
Annual report
4:02pm
424B4
ouvzd 3t7lsmdut
16 Feb 21
Prospectus supplement with pricing info
4:38pm
S-1/A
kaqewu ru
8 Feb 21
IPO registration (amended)
7:29am
S-1
hbtrb6lm lnf
19 Jan 21
IPO registration
4:38pm
DRS/A
ukitig2m
15 Jan 21
Draft registration statement (amended)
12:00am
DRS
o6yj72j 8dgxc
14 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next